| |
| |
|
| Insider
Information: |
Bradbury Daniel |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
223,469 |
|
|
Indirect Shares
|
3,161,475 |
|
|
| Direct
Value |
$2,602,212 |
|
|
|
Indirect Value
|
$3,786,678 |
|
|
| Total
Shares |
3,384,944 |
|
|
| Total
Value |
$6,388,890 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amylin Pharmaceuticals Inc |
AMLN |
President & Chief Exec... |
2012-08-08 |
0 |
2012-08-08 |
0 |
Premium* |
|
|
Paratek Pharmaceuticals Inc |
PRTK |
Director |
2006-05-09 |
35,714 |
|
0 |
Premium* |
|
|
Illumina Inc |
ILMN |
Director |
2017-05-25 |
15,324 |
2008-05-16 |
0 |
Premium* |
|
|
Corcept Therapeutics Inc |
CORT |
Director |
2012-11-21 |
0 |
2019-02-07 |
130,575 |
Premium* |
|
|
Geron Corporation |
GERN |
Director |
2014-05-09 |
142,776 |
2019-03-29 |
51,323 |
Premium* |
|
|
Equillium Inc |
EQ |
Chief Executive Office... |
2018-10-16 |
0 |
2018-10-16 |
2,969,596 |
Premium* |
|
|
Castle Biosciences Inc |
CSTL |
Director |
2024-05-06 |
4,655 |
2024-05-06 |
9,981 |
Premium* |
|
|
Nuvation Bio Ord Shs Class A |
NUVB |
Director |
2021-02-10 |
25,000 |
2021-02-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
423 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 17
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMLN |
Amylin Pharmaceuticals In... |
President & Chief Executive Of |
• – – |
2012-08-08 |
4 |
D |
$31.00 |
$3,880,623 |
I/I |
(125,181) |
0 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
President & Chief Executive Of |
• – – |
2012-08-08 |
4 |
D |
$31.00 |
$3,036,301 |
D/D |
(97,945) |
0 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
• – – |
2005-10-07 |
4 |
AS |
$34.75 |
$69,500 |
I/I |
(2,000) |
481 |
|
- |
|
| CSTL |
Castle Biosciences Inc |
Director |
– • – |
2022-06-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
830 |
830 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2008-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
1,000 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2008-06-18 |
4 |
AS |
$81.67 |
$245,019 |
D/D |
(3,000) |
1,000 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2008-07-23 |
4 |
AS |
$90.95 |
$272,838 |
D/D |
(3,000) |
1,000 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2008-08-19 |
4 |
AS |
$91.24 |
$276,728 |
D/D |
(3,000) |
1,000 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2008-08-19 |
4 |
OE |
$8.07 |
$24,210 |
D/D |
3,000 |
1,400 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
President & Chief Exec Officer |
• – – |
2007-04-09 |
4 |
AS |
$38.66 |
$96,657 |
I/I |
(2,500) |
1,597 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2010-12-09 |
4 |
AS |
$62.73 |
$401,514 |
D/D |
(6,400) |
1,800 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2010-12-09 |
4 |
OE |
$13.30 |
$85,120 |
D/D |
6,400 |
1,900 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2010-07-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,865 |
1,937 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2010-08-10 |
4 |
AS |
$46.45 |
$297,376 |
D/D |
(6,400) |
1,937 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2010-09-10 |
4 |
AS |
$44.33 |
$284,191 |
D/D |
(6,400) |
1,937 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2010-10-04 |
4 |
AS |
$49.42 |
$317,525 |
D/D |
(6,400) |
1,937 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2010-11-02 |
4 |
AS |
$54.39 |
$348,103 |
D/D |
(6,400) |
1,937 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
• – – |
2004-12-10 |
4 |
GA |
$0.00 |
$0 |
I/I |
2,000 |
2,000 |
|
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2008-10-21 |
4 |
AS |
$32.59 |
$195,835 |
D/D |
(6,000) |
2,000 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2010-03-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
137 |
2,000 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2010-08-10 |
4 |
OE |
$4.04 |
$25,824 |
D/D |
6,400 |
2,037 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2010-02-26 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,703 |
2,137 |
0 |
- |
|
| ILMN |
Illumina Inc |
Director |
– • – |
2010-03-02 |
4 |
AS |
$38.04 |
$137,317 |
D/D |
(3,600) |
2,137 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
• – – |
2005-09-08 |
4 |
AS |
$31.75 |
$63,500 |
I/I |
(2,000) |
2,481 |
|
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
President & Chief Operating |
• – – |
2006-12-07 |
4 |
AS |
$39.35 |
$98,369 |
I/I |
(2,500) |
2,496 |
0 |
- |
|
423 Records found
|
|
Page 1 of 17 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
